The Cure

Not quite a year ago at US Department of Energy Joint Genome Institute's seventh annual User Meeting, Carl Zimmer opined that there were too many new genome sequences coming out and that he was weary of them, diagnosing himself with what he dubbed 'Yet Another Genome Syndrome,' or YAGS. Now, though, he writes on his blog that he's been cured.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.